Perrigo Company Plc
A maker of over-the-counter self-care products, Perrigo supplies store-brand medicines to retailers and also sells its own brands like Opill®, Mederma®, Compeed®, and Solpadeine® across North America and Europe. The company traces back to 1887, when Michigan general-store owner Luther Perrigo began packaging medicines and household goods for other country stores — and pioneered the private-label idea by printing each store's own name on the labels. The company still bears his name today.
Granted 9.3K · Bought 400.0K
Granted 439.9K · Sold 761
Granted 109.0K · Bought 21.5K · Sold 35.0K
Granted 171.3K · Bought 25.0K
Granted 63.4K · Bought 43.4K
Granted 176.5K · Sold 30.2K
Granted 104.0K · Bought 8.0K
Granted 28.1K · Bought 14.0K
Granted 107.9K · Bought 6.2K · Sold 12.6K
Granted 43.4K · Bought 27.5K
Granted 77.0K · Bought 13.4K
Granted 62.4K · Bought 13.0K
Granted 100.1K · Sold 37.2K
Granted 66.6K
Granted 58.0K · Sold 9.8K
Granted 43.3K · Sold 17.5K
Granted 61.2K · Sold 13.8K
Granted 53.3K
Granted 53.1K
Granted 32.9K · Sold 5.8K
Granted 58.4K · Sold 9.0K
Granted 35.0K
Granted 51.0K · Sold 4.4K
Granted 25.3K
Granted 12.1K · Sold 674
Granted 13.4K · Bought 6.1K
Granted 21.2K
Granted 24.1K · Bought 4.9K
Granted 31.5K
Granted 17.8K · Sold 3.7K
Granted 22.8K
Granted 15.1K
Granted 28.8K
Granted 2.5K · Bought 7.5K
Granted 15.9K
Granted 75.9K · Sold 37.9K
Granted 54.2K · Sold 17.6K
Granted 30.9K · Sold 19.3K
Granted 79.7K · Sold 57.0K
Granted 4.4K
Granted 10.5K
Granted 10.4K
Granted 10.6K
Granted 6.7K · Bought 1.0K
Bought 7.5K
Granted 9.8K · Sold 826
Granted 9.3K
Granted 7.0K · Bought 1.3K
Granted 28.8K · Sold 9.0K
Granted 6.4K
Granted 7.8K · Sold 2.0K
Granted 9.9K · Sold 4.5K
Granted 5.3K
Granted 7.3K
Granted 4.1K
Granted 355.6K · Bought 15.7K · Sold 197.6K
Granted 3.2K · Bought 700 · Sold 1.0K
Granted 1.3K
Granted 924
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Smith Jeffrey CDirector · 24 transactions | — | 13.33Mas of May 2019 | 9.3K | 400.0K | — |
| Jandernoa Michael JDirector · 38 transactions | — | 758.6Kas of Feb 2017 | 439.9K | — | 761 |
| Andersen SvendEVP & President CHCI · 40 transactions | — | 175.6Kas of Aug 2024 | 109.0K | 21.5K | 35.0K |
| Lockwood-Taylor PatrickFormer CEO and director · 23 transactions | — | 123.2K | 171.3K | 25.0K | — |
| Parker Geoffrey M.Director · 33 transactions | — | 122.8K | 63.4K | 43.4K | — |
| Papa Joseph CCEO, Director · 25 transactions | — | 118.5Kas of Mar 2016 | 176.5K | — | 30.2K |
| Bezerra Eduardo GuaritaEVP & Chief Financial Officer · 26 transactions | — | 84.7K | 104.0K | 8.0K | — |
| Samuels Theodore R. IIDirector · 11 transactions | — | 83.0Kas of May 2022 | 28.1K | 14.0K | — |
| Kingma Todd WExecutive VP, General Counsel · 74 transactions | — | 64.2Kas of Jun 2024 | 107.9K | 6.2K | 12.6K |
| Silcock RaymondEVP, Chief Financial Officer · 13 transactions | — | 59.5Kas of Apr 2022 | 43.4K | 27.5K | — |
| Willis RobertEVP & CHRO · 72 transactions | — | 52.4K | 77.0K | 13.4K | — |
| Alford Bradley ADirector · 23 transactions | — | 45.5K | 62.4K | 13.0K | — |
| Janish Ronald CraigEVP, Gbl Ops & SC & CTO · 73 transactions | — | 40.6Kas of Jun 2025 | 100.1K | — | 37.2K |
| O'Connor DonalDirector · 24 transactions | — | 39.1K | 66.6K | — | — |
| Kochan SharonEVP & President Rx · 41 transactions | — | 35.1Kas of Mar 2021 | 58.0K | — | 9.8K |
| Hendrickson John TCEO · 34 transactions | — | 33.1Kas of Dec 2017 | 43.3K | — | 17.5K |
| Needham JeffreyEVP, President CHC Americas · 48 transactions | — | 32.1Kas of Jun 2020 | 61.2K | — | 13.8K |
| Ashford Orlando DDirector · 12 transactions | — | 27.7K | 53.3K | — | — |
| Karaboutis AdrianaDirector · 16 transactions | — | 27.6Kas of May 2025 | 53.1K | — | — |
| Kunkle Gary K JrDirector · 10 transactions | — | 25.7Kas of Sep 2016 | 32.9K | — | 5.8K |
| Dillard James E IIIEVP & President CSCA · 29 transactions | — | 25.1Kas of Mar 2023 | 58.4K | — | 9.0K |
| Mann Erica LDirector · 10 transactions | — | 21.7Kas of May 2024 | 35.0K | — | — |
| Quinn GrainneEVP, Chief Medical Officer · 54 transactions | — | 21.1Kas of Apr 2024 | 51.0K | — | 4.4K |
| Cohen Gary MDirector · 10 transactions | — | 20.3Kas of Nov 2018 | 25.3K | — | — |
| Yu LouisExecutive VP Global Quality · 12 transactions | — | 19.1Kas of Aug 2015 | 12.1K | — | 674 |
| Ives AlisonEVP & Chief Scientific Officer · 26 transactions | — | 18.5Kas of Jul 2024 | 13.4K | 6.1K | — |
| Brlas LaurieDirector · 11 transactions | — | 17.9Kas of Jun 2018 | 21.2K | — | — |
| Classon Rolf ADirector · 10 transactions | — | 17.4Kas of Dec 2021 | 24.1K | 4.9K | — |
| Manzone AlbertDirector · 8 transactions | — | 16.4K | 31.5K | — | — |
| Gottfried RanDirector · 10 transactions | — | 15.5Kas of Nov 2015 | 17.8K | — | 3.7K |
| Brown Julia MDirector · 6 transactions | — | 15.3K | 22.8K | — | — |
| Gibbons David TDirector · 4 transactions | — | 15.1Kas of Nov 2015 | 15.1K | — | — |
| Khoury RobertoEVP and President of CSCI · 10 transactions | — | 13.1K | 28.8K | — | — |
| Sorota Richard SEVP & President CSCA · 3 transactions | — | 11.2Kas of Mar 2021 | 2.5K | 7.5K | — |
| Hanson KyleEVP & General Counsel · 6 transactions | — | 11.1Kas of Apr 2024 | 15.9K | — | — |
| Farrington ThomasEVP and CIO · 89 transactions | — | 10.7Kas of Apr 2024 | 75.9K | — | 37.9K |
| Kindler Jeffrey BDirector · 19 transactions | — | 10.6Kas of May 2025 | 54.2K | — | 17.6K |
| Morris Herman JrDirector · 15 transactions | — | 10.2Kas of Sep 2016 | 30.9K | — | 19.3K |
| Brown Judy LEVP, Business Ops & CFO · 51 transactions | — | 10.0Kas of Nov 2016 | 79.7K | — | 57.0K |
| Weninger PaulEVP, Quality Operations · 13 transactions | — | 9.7Kas of Feb 2019 | 4.4K | — | — |
| Hoffing Ellen RandiDirector · 5 transactions | — | 9.1Kas of May 2016 | 10.5K | — | — |
| Samuelson JonasDirector · 4 transactions | — | 8.9K | 10.4K | — | — |
| Ball DavidEVP & CBDO · 4 transactions | — | 7.8K | 10.6K | — | — |
| Atkinson CharlesEVP, General Counsel & Sec. · 3 transactions | — | 7.7K | 6.7K | 1.0K | — |
| Roehrhoff UweCEO, Director · 2 transactions | — | 7.5Kas of Mar 2018 | — | 7.5K | — |
| Winowiecki RonaldCFO · 19 transactions | — | 7.0Kas of Aug 2019 | 9.8K | — | 826 |
| Schmelter TrionaEVP & President CSCA · 6 transactions | — | 6.7Kas of Jun 2025 | 9.3K | — | — |
| Lennox AbigailEVP and CSO · 5 transactions | — | 6.6K | 7.0K | 1.3K | — |
| Doyle Katherine C.Director · 9 transactions | — | 6.0Kas of Sep 2024 | 28.8K | — | 9.0K |
| Jamison Scott FExecutive Vice President PBM · 9 transactions | — | 5.2Kas of Aug 2015 | 6.4K | — | — |
| Shah JatinSr VP & Chief Scientific Offic · 10 transactions | — | 4.5Kas of Aug 2015 | 7.8K | — | 2.0K |
| Stewart Michael RobertSr. VP Global Human Resources · 16 transactions | — | 4.3Kas of Aug 2015 | 9.9K | — | 4.5K |
| Fouse Jacqualyn ADirector · 5 transactions | — | 3.9Kas of May 2016 | 5.3K | — | — |
| Egan Kevin FrancisDirector · 2 transactions | — | 3.8K | 7.3K | — | — |
| Zilberfarb Ben-ZionDirector · 2 transactions | — | 3.2Kas of Dec 2013 | 4.1K | — | — |
| Kessler Murray SCEO, Director · 31 transactions | — | 2.7Kas of May 2023 | 355.6K | 15.7K | 197.6K |
| Wesolowski JohnEVP, President Rx · 22 transactions | — | 2.6Kas of Feb 2019 | 3.2K | 700 | 1.0K |
| Boothe DouglasEVP & GM Perrigo Pharma · 5 transactions | — | 803as of Mar 2016 | 1.3K | — | — |
| Yanai ShlomoDirector · 2 transactions | — | 443as of May 2016 | 924 | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +89.3K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.